1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features
Cellular kinases are crucial for the transcription/replication of many negative-strand RNA viruses and might serve as targets for antiviral therapy. In this study, a library comprising 80 kinase inhibitors was screened for antiviral activity against vesicular stomatitis virus (VSV), a prototype memb...
Main Authors: | Sarah Moeschler, Samira Locher, Gert Zimmer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/10/6/306 |
Similar Items
-
Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies
by: Tatiana A. Korolenko, et al.
Published: (2020-10-01) -
1-Benzyl-3-methylimidazolium bromide
by: Tim Peppel, et al.
Published: (2020-06-01) -
Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation
by: Tomoki Kuwahara, et al.
Published: (2020-11-01) -
Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
by: Markus Blaess, et al.
Published: (2020-11-01) -
The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
by: Michal Stark, et al.
Published: (2020-04-01)